Substrate
science

Book Examines Industrial Honeybee Farming Practices in the United States

Jennie Durant's Bitter Honey reviews the operational methods and mortality rates associated with commercial beekeeping in the U.S. The review notes that mortality statistics alone may not lead to policy or consumer changes.

New Scientist
1 source·May 28, 8:54 AM(1 day ago)·1m read
Book Examines Industrial Honeybee Farming Practices in the United Statesanothermag.com
Audio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.

Jennie Durant's book Bitter Honey examines the operational methods used in commercial honeybee management across the United States. Thomas Lewton reviewed the book for New Scientist and described it as an exposé of the costs tied to industrial-scale beekeeping.

The review states that the book presents figures on bee deaths and questions whether those numbers alone will prompt broader changes in practice.

Lewton suggests that viewing honeybees as fellow creatures could supplement the data presented in the book. No specific mortality rates, regulatory actions, or company names are provided in the review.

Key Facts

Book title
Bitter Honey by Jennie Durant
Reviewer
Thomas Lewton for New Scientist
Subject
Industrial honeybee management in the U.S.

Transparency Panel

Sources cross-referenced1
Confidence score75%
Synthesized bySubstrate AI
Word count92 words
PublishedMay 28, 2026, 8:54 AM
Bias signals removed2 across 1 outlet
Signal Breakdown
Loaded 1Framing 1

Related Stories

WHO Director Visits Congo as Ebola Outbreak SpreadsNpr
science4 hrs ago

WHO Director Visits Congo as Ebola Outbreak Spreads

The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.

Npr
France 24
2 sources
FDA Panel Recommends XFG Variant for Fall Covid Shotsmedpagetoday.com
science2 hrs agoDeveloping

FDA Panel Recommends XFG Variant for Fall Covid Shots

Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.

Stat
1 source
Benzinga Publishes Article on Biotech Stocks During Pandemic Recoveryfinance.yahoo.com
science6 hrs agoDeveloping

Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery

Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…

Benzinga
1 source